BSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.
Mangalam Drugs and Organics Ltd: key numbers
- Share price
- ₹29.10
- Market cap
- ₹46.06 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.2×Sector 46.1×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangalam Drugs and Organics Ltd
All →Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs issued a postal ballot notice seeking approval to re-appoint Praveen Saxena as independent director for a second five-year term. Voting closes 17 June 2026.
Mangalam Drugs and Organics Debt & Borrowing: ₹1,557 Cr
Mangalam Drugs and Organics Limited has reported a default amounting to Rs.1,557.27 Crore. The company has submitted a restructuring proposal to its banks to manage the obligation.
- Value
- ₹1,557 Cr
Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr
Mangalam Drugs and Organics Limited reported defaults on bank loan obligations totaling Rs. 15.57 Crore. The defaults involve cash credit accounts at Bank of Maharashtra and Bank of Baroda.
- Value
- ₹15.57 Cr
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs and Organics Limited has issued a Postal Ballot notice to seek shareholder approval for appointing Shri Prabhakar Raghunath Zavar as an Independent Director. The appointment is for five years.
Mangalam Drugs and Organics Other Announcement
Mangalam Drugs and Organics Limited announced the appointment of new Statutory and Secretarial Auditors following the tenure completion of the previous Statutory Auditor.
Mangalam Drugs and Organics Management Change
Manglam Drugs and Organics Ltd. has appointed M/s S.N. Nanda & Co. as Statutory Auditor and M/s L.N. Joshi & Co. as Secretarial Auditor.
Other board meeting date announcements
All →Elpro International Board Meeting Date
Elpro International's board meets November 3, 2026 to approve September quarter and half-year results. Trading window stays closed from October 1 until 48 hours after release.
Bella Casa Fashion & Retail Board Meeting Date
Bella Casa Fashion & Retail gave prior notice of a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window closure is also noted.
Consecutive Commodities Board Meeting Date
Consecutive Commodities will hold a board meeting on 3 November 2026 to consider unaudited quarterly and half-year results. Agenda items are proposed only, not yet approved.
Radhika Jeweltech Board Meeting Date
Radhika Jeweltech will hold a board meeting on November 3, 2026 to consider unaudited quarterly results. The trading window reopens 48 hours after results are declared.
Technopack Polymers Board Meeting Date
Technopack Polymers will hold a board meeting on 4 November 2026 to consider unaudited standalone results for the half year ended 30 September 2026. Trading window closes from 1 October 2026 until 48 hours after the results are made public.
Shlokka Dyes Board Meeting Date
Shlokka Dyes scheduled a board meeting for November 3, 2026 to consider half-year results and fund-raising. Agenda items are proposed and subject to approvals.